New scorecard shows inequalities in osteoporosis care in the Europe Union (EurekAlert, 17 April 2013)

Hair analysis reveals elevated stress hormone levels raise cardiovascular risk (EurekAlert, 17 April 2013)

Common osteoporosis drug slows formation of new bone (EurekAlert, 17 April 2013)

18 Apr 2013

A study from Italy published in Journal of Clinical Endocrinology & Metabolism assesses sclerostin levels as a measure of bone formation in women treated with zoledronic acid.

Related Topics

Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid

Share this story

Top stories

Call for nominations for Awards Committee Chair
30 Oct 2024

James M Tanner Award - 2025 nominations open
30 Oct 2024

Would you like to host the BSPED annual meeting?
21 Oct 2024

Most read